MONTREAL—Today, the Society for Cardiovascular Angiography & Interventions (SCAI) announced its 2026 Master Interventionalists of SCAI (MSCAI) designation recipients during the SCAI 2026 Scientific Sessions & CAIC-ACCI Summit, held April 23-25, in Montréal, Canada. 

The MSCAI designation is awarded to individuals who have demonstrated excellence in invasive/interventional cardiology over the course of their career and for their commitment to the highest levels of clinical care, innovation, publication, and teaching.  

This year’s MSCAI designations were awarded to the following group of outstanding interventionalists: 

Media Contact

Gavin Stern 

[email protected], 202-644-8561 

About SCAI Scientific Sessions 2026 

The SCAI Scientific Sessions annual meeting convenes nearly 2,000 of the world’s premier clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine. With 500+ faculty and hundreds of abstracts, experts in the field work together to share the latest clinical data, procedural guidance, and advanced expertise. Highlights include live cases, featured clinical research, new SCAI clinical documents, case-based learning, and keynote speakers. For more information, visit SCAI 2026 Scientific Sessions. 

About the Society for Cardiovascular Angiography & Interventions (SCAI) 

The Society for Cardiovascular Angiography and Interventions is a professional organization representing more than 5,000 invasive and interventional cardiology professionals in approximately 75 nations. SCAI's mission is to promote excellence in invasive/interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. For more information, visit SCAI.ORG.